Nav: Home

Readily available drug cocktail can help prevent sepsis shock and death

June 26, 2017

GLENVIEW, IL, June 26, 2017 - Sepsis presents a major challenge for health care providers, especially in low-income countries where the mortality rate can exceed 60 percent. Even in advanced medical settings, sepsis is still very dangerous and accounts for over 400,000 deaths annually in the U.S. alone. While new drugs are in development, a group of researchers has determined that a combination of intravenous vitamin C, corticosteroids (a steroid), and thiamine (vitamin B) may be effective in preventing progressive organ dysfunction and reducing the number of deaths from severe sepsis and septic shock. Their findings are published in the June issue of CHEST.

"New therapeutic approaches to sepsis are desperately required," explained lead investigator Paul E. Marik, MD, Chief, Pulmonary and Critical Care Medicine, Department of Internal Medicine, Eastern Virginia Medical School, Norfolk, VA. "Our results suggest that early use of intravenous vitamin C, together with corticosteroids and thiamine may prove to be effective in preventing progressive organ dysfunction, including acute kidney injury, and reducing the mortality of patients with severe sepsis and septic shock."

In this observational before-and-after study, investigators looked at patients treated with their "metabolic resuscitation protocol" of vitamin C, corticosteroids, and thiamine. After finding early success with three seemingly terminal cases, researchers treated patients with sepsis in their ICU using the cocktail. The team then established a control group by examining medical records of similar patients who had been hospitalized prior to the initiation of the new protocol. They found that patients who received this novel treatment improved much more quickly than those in the control group and had a much lower hospital death rate. In the control group not treated with the protocol, 40 percent of patients died in the hospital versus 9 percent in the treatment group.

Along with fewer deaths, the protocol also reduced the duration of vasopressor use. In the control group, the mean duration for vasopressor use was 54.9 ? 28.4 hours, but in the treatment group, that time was significantly reduced to 18.3 ? 9.8 hours. Also of note, no patient in the treatment group developed progressive organ failure, and the four deaths in the group were not from sepsis but from underlying medical conditions they had before developing sepsis.

Investigators believe that the combination of vitamin C, hydrocortisone and thiamine works synergistically to reverse the pathophysiologic changes of sepsis. Vitamin C is a crucial antioxidant, vital to preserving endothelial function and microcirculatory flow. Predictably, patients with sepsis have very low serum levels of vitamin C that can only be corrected through the administration of intravenous vitamin C. In the study, patients were given 6 g of vitamin C per day, for which no complications or side effects have been reported, along with hydrocortisone doses according to consensus guidelines from the American College of Critical Care Medicine. Thiamine was included to combat thiamine deficiency, which has been linked to an increased risk of death in patients with sepsis.

While other studies have examined the safety and efficacy of these components by themselves, this is the first study to evaluate them together. "We did not test an expensive, proprietary designer molecule, but rather a combination of three cheap and readily available agents with a long safety record in clinical use since 1949," concluded Dr. Marik. "Due to the inherent safety of the combination of hydrocortisone, vitamin C, and thiamine, we believe that this treatment strategy can be adopted pending the results of further clinical trials. This inexpensive intervention has the potential to reduce the global mortality for sepsis." Dr. Marik also acknowledged all those scientists dating back to 1747, who have done seminal research in this area and on whose work this study concept was based.
-end-


Elsevier

Related Sepsis Articles:

Readily available drug cocktail can help prevent sepsis shock and death
Even in advanced medical settings, sepsis is still very dangerous and accounts for over 400,000 deaths annually in the US alone.
A rusty and sweet side of sepsis
A research team led by Miguel Soares at the Instituto Gulbenkian de Ciência (IGC) in Portugal discovered an unsuspected mechanism that is protective against sepsis.
New pediatric protocol reduces missed sepsis diagnoses by 76 percent
An electronic sepsis alert using a combination of vital signs, risk factors and physician judgment to identify children in a pediatric emergency department with severe sepsis reduced missed diagnoses by 76 percent.
Machine learning may help in early identification of severe sepsis
A machine-learning algorithm has the capability to identify hospitalized patients at risk for severe sepsis and septic shock using data from electronic health records (EHRs), according to a study presented at the 2017 American Thoracic Society International Conference.
Faster is better when it comes to sepsis care
An analysis covering nearly 50,000 patients from 149 New York hospitals is the first to offer scientific evidence that a controversial early sepsis care regulation worked.
Prompt sepsis treatment less likely when ERs overcrowded
According to a new study, patients with sepsis, a life-threatening complication of an infection, had delays approaching one hour in being given antibiotics when seen in emergency rooms that were overcrowded.
New test to rapidly diagnose sepsis
Researchers have developed a test that can rapidly and reliably diagnose sepsis, a potentially life-threatening complication of bacterial infections.
Children who survive sepsis often experience lingering effects
Survival rates have risen dramatically in recent years among children who develop sepsis, a severe, life-threatening immune reaction to an infection somewhere in the body.
Recognize sepsis as a separate cause of illness and death
Sepsis should be recognized as a separate cause of illness and death around the world.
Simple measures cut sepsis deaths nearly in half
Sepsis, also called blood poisoning, is a common affliction that can affect people of all ages.

Related Sepsis Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...